[Antihymenolepidose activity of the compound MCT-22: preparation and study].
Mikhaĭlitsyn
F S
FS
Gitsu
G A
GA
Sevbo
D P
DP
Trusov
S N
SN
Bolotina
L A
LA
D000818:Animals; D000923:Anticestodal Agents / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D001549:Benzamides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006925:Hymenolepiasis / Q000188:drug therapy*; D048189:Hymenolepis nana / Q000187:drug effects*; D051379:Mice; D009578:Nitrobenzenes / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*
D000923:Anticestodal Agents; D001549:Benzamides; C553387:N-(2-chloro-4-nitrophenyl)-2-acetoxy-3,5-dichlorobenzamide; D009578:Nitrobenzenes